Head to head
Verisk Analytics vs Equifax
Side-by-side on the measures that matter, with a plain-English read. Full detail: VRSK · EFX
VRSK
Verisk Analytics
168.68+2.11%
1-year price shape — -31% over the period
Quant Rating E · 11/100
vs
EFX
Equifax
142.43-0.04%
1-year price shape — -39% over the period
Quant Rating E · 7/100
1-year performance, rebased to 100
Verisk Analytics edges it on the scoreable measures. Verisk Analytics has the highest Quant Rating (11); Verisk Analytics has done best over the past year (-31%); Verisk Analytics earns the most per share.
| VRSK | EFX | |
|---|---|---|
| Snapshot | ||
| Sector | -- | Consulting Services |
| Last price | 168.68 | 142.43 |
| Change today | +2.11% | -0.04% |
| 1-year return | -30.8% | -39.5% |
| Market cap | $21.95B | $16.73B |
| 52-week range | 155.10 – 243.24 | 137.01 – 236.24 |
| Valuation | ||
| P/E (TTM) | 25.91 | 25.03 |
| P/E percentile, own 5-yr range | 1st | 2nd |
| P/B | -18.47 | 3.82 |
| Dividend yield | 1.13% | 1.49% |
| Profitability & growth | ||
| EPS (TTM) | 6.48 | 5.32 |
| Net profit (TTM) | $843.41M | $625.02M |
| Revenue (TTM) | $3.14B | $6.44B |
| Revenue growth (YoY) | +4.4% | +10.6% |
| Gross margin | 70.2% | 55.5% |
| Operating margin | 43.9% | 17.9% |
| Net margin | 28.2% | 10.7% |
| Free cash flow (TTM) | $1.24B | $1.11B |
| Ownership & sentiment | ||
| Institutional ownership | 100.7% | 103.2% |
| Insider activity (12mo) | 27 buy / 22 sell | 35 buy / 15 sell |
| Short interest (% of float) | 3.6% | 6.6% |
| Analyst consensus | 54% buy / 46% hold (13) | 75% buy / 25% hold (20) |
| Analyst price target | $236 (+40%) | $210 (+47%) |
| StockVane view | ||
| StockVane Quant Rating | E (11) | E (7) |
| Company | ||
| Employees | 8,000 | 15,000 |
| Founded | 1971 | 1899 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.